Related Experiment Video
Updated: Jan 27, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?
Angeliki Zarkali1, Suk Fun Cheng2, Agnes Dados1
1Hyperacute Stroke Unit, University College London Hospital, United Kingdom.
Insights
Atrial fibrillation (AF) affects 9% of patients with ischemic monocular blindness, often going undetected. Management of known AF was suboptimal, with many eligible patients not receiving anticoagulation.
Area of Science:
- Cardiology
- Neurology
- Ophthalmology
Background:
- Atrial fibrillation (AF) is a primary cause of ischemic stroke and TIA.
- Retinal ischemic monocular blindness is typically linked to carotid artery disease (CAS), with less focus on AF screening.
- This study investigated the prevalence of AF in patients experiencing ischemic monocular blindness.
Purpose of the Study:
- To determine the prevalence of atrial fibrillation (AF) in patients presenting with ischemic monocular blindness.
- To assess the diagnostic yield of cardiac monitoring in this patient group.
- To evaluate the management of anticoagulation in AF patients with ischemic monocular blindness.
Main Methods:
- Retrospective review of 400 consecutive patients presenting with ischemic monocular blindness to a TIA clinic (Jan 2014-Oct 2016).
- Analysis included patient demographics, event type (transient vs. permanent), cardiac monitoring, carotid imaging, and AF diagnosis.
- Comparison of comorbidities and anticoagulation status between AF and non-AF groups.
Main Results:
- Of 400 patients, 9% were diagnosed with AF; 14% had significant ipsilateral carotid artery disease (CAS).
- Only 53% of patients underwent prolonged cardiac monitoring, suggesting the 9% AF prevalence is an underestimate.
- Among diagnosed AF patients, only 55% were on anticoagulation, despite eligibility (CHADVASC2 score ≥1).
- AF patients exhibited higher rates of hypertension, prior TIA, prior stroke, and ischemic heart disease.
Conclusions:
- A significant proportion of patients with ischemic monocular blindness have undiagnosed or undertreated atrial fibrillation.
- Current diagnostic strategies may underestimate AF prevalence due to limited cardiac monitoring.
- Anticoagulation management for AF in this cohort is suboptimal, increasing stroke risk.
Introduction:
Atrial fibrillation (AF) is a major cause of ischemic stroke and Transient Ischemic Attack (TIA) and investigation for paroxysmal AF is recommended following an embolic brain event. In contrast, retinal ischemic monocular blindness is traditionally considered most linked to carotid artery disease (CAS) and investigating for AF is less vigilant. We aimed to determine the prevalence of AF in patients with ischemic monocular blindness.
Methods:
Consecutive records of all patients presenting to a daily TIA clinic with transient or permanent ischemic monocular blindness were reviewed, January 2014-October 2016.
Results:
Of 400 patients, 224 (56.0%) were male, mean age 64.5 years (SD 15.1). A total of 263 (66%) presented with transient and 137 (34%) with permanent ischemic monocular blindness. ECG was performed in 364 patients (91%) but only 211 (52%) had further cardiac monitoring. The vast majority (97.3%) had carotid imaging. Thirty-six patients (9%) were found to have AF while 53 (14%) had ipsilateral CAS. Median ABCD2 score was 1 in AF and non-AF groups. Only 55% of known AF patients were anticoagulated at presentation, despite all having CHADVASC2 score greater than or equal to 1. Patients with AF had more hypertension (P = .004), previous TIA (P = .002), previous stroke (P = .044) and ischemic heart disease (P = .022) with no difference in age (P = .791), diabetes (P = .563), smoking (P = .460) nor hypercholesterolaemia (P = .083).
Conclusions:
A total of 9% of patients with ischemic monocular blindness had AF. This is an underestimate, as only 53% of patients had prolonged cardiac monitoring. Known AF was suboptimally managed with only 55% receiving anticoagulation despite being eligible.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Major Losses in Pipes
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...

